Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
What the clinical research actually shows Separating marketing claims from actual research data is essential for anyone considering this combination
The companys most advanced candidate, axicabtagene ciloleucel (axi-cel), is a CAR-T therapy that at the time of the deal was under priority review by the FDA for refractory aggressive non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL), transformed follicular lymphoma (TFL) and primary mediastinal B-cell lymphoma (PMBCL)
The delivery included a dedicated bag for sharps, alcohol swabs, and Hims-branded patient information cards with dosing and storage instructions
I noticed a steady reduction in cravings, improved portion control, and consistent progress over time
